STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell–induced CD4+ T cell tolerance

Journal:

Science Advances

Published:

2026-01-02

DOI:

10.1126/sciadv.adv8860

Affiliations:

5

Authors:

15

Go to article

Institutions	Authors	Share
Northwestern Medicine, United States of America (USA)	11.166667 11.166667	0.74
Cour Pharmaceuticals Development Co., Inc. (Cour), United States of America (USA)	2.833333	0.19
University of Michigan (U-M), United States of America (USA)	1.000000	0.07

Interested in Immunology?